Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean A Regier

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Journal of Health Economics|April 7, 2009
Bayesian and classical estimation of mixed logit: An application to genetic testingDean A Regier, Mandy Ryan, Euan Phimister, et al.
BMC Health Services Research|January 27, 2021
Describing practices of priority setting and resource allocation in publicly funded health care systems of high-income countriesBrayan V Seixas, Dean A Regier, Stirling Bryan, et al.
Cancer|September 24, 2019
Health-related quality of life in oncology drug reimbursement submissions in Canada: A review of submissions to the pan-Canadian Oncology Drug ReviewAdam J N Raymakers, Dean A Regier, Stuart J Peacock
Journal of Cancer Survivorship : Research and Practice|September 30, 2022
Mapping the experiences of people with advanced cancer across multiple cancer types-a scoping reviewSteve E Kalloger, Cheryl Ho, Craig Mitton, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Cost-effectiveness of tumor necrosis factor-alpha antagonists in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitisDean A Regier, Nick Bansback, Anne Dar Santos, et al.
Current Oncology (Toronto, Ont.)|June 2, 2021
Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of CareAdam J N Raymakers, David Cameron, Scott Tyldesley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 5, 2023
Toward Best Practices for Economic Evaluations of Tumor-Agnostic Therapies: A Review of Current Barriers and SolutionsDeirdre Weymann, Samantha Pollard, Halina Lam, et al.
European Journal of Human Genetics : EJHG|May 27, 2018
Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experimentDeirdre Weymann, David L Veenstra, Gail P Jarvik, et al.
The Patient|September 3, 2020
Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient ValuesSarah Costa, Dean A Regier, Adam J N Raymakers, et al.
PLOS Digital Health|March 12, 2026
Advancing the science of qualitative patient preference assessment using large language modelsTed Grover, Emanuel Krebs, Deirdre Weymann, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Journal of Health Economics|April 7, 2009
Bayesian and classical estimation of mixed logit: An application to genetic testingDean A Regier, Mandy Ryan, Euan Phimister, et al.
BMC Health Services Research|January 27, 2021
Describing practices of priority setting and resource allocation in publicly funded health care systems of high-income countriesBrayan V Seixas, Dean A Regier, Stirling Bryan, et al.
Cancer|September 24, 2019
Health-related quality of life in oncology drug reimbursement submissions in Canada: A review of submissions to the pan-Canadian Oncology Drug ReviewAdam J N Raymakers, Dean A Regier, Stuart J Peacock
Journal of Cancer Survivorship : Research and Practice|September 30, 2022
Mapping the experiences of people with advanced cancer across multiple cancer types-a scoping reviewSteve E Kalloger, Cheryl Ho, Craig Mitton, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Cost-effectiveness of tumor necrosis factor-alpha antagonists in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitisDean A Regier, Nick Bansback, Anne Dar Santos, et al.
Current Oncology (Toronto, Ont.)|June 2, 2021
Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of CareAdam J N Raymakers, David Cameron, Scott Tyldesley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 5, 2023
Toward Best Practices for Economic Evaluations of Tumor-Agnostic Therapies: A Review of Current Barriers and SolutionsDeirdre Weymann, Samantha Pollard, Halina Lam, et al.
European Journal of Human Genetics : EJHG|May 27, 2018
Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experimentDeirdre Weymann, David L Veenstra, Gail P Jarvik, et al.
The Patient|September 3, 2020
Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient ValuesSarah Costa, Dean A Regier, Adam J N Raymakers, et al.
PLOS Digital Health|March 12, 2026
Advancing the science of qualitative patient preference assessment using large language modelsTed Grover, Emanuel Krebs, Deirdre Weymann, et al.
Pageof 13